| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0009 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |